Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amrita Basu

Showing results (51-60 of 74) with videos related to

Pageof 8
Sort By:
JAMIA Open|June 7, 2021
PRoBE the cloud toolkit: finding the best biomarkers of drug response within a breast cancer clinical trialNicholas O'Grady, David L Gibbs, Kawther Abdilleh, et al.
Frontiers in Oncology|June 29, 2023
Computational drug repositioning for the identification of new agents to sensitize drug-resistant breast tumors across treatments and receptor subtypesKatharine Yu, Amrita Basu, Christina Yau, et al.
Disease Models & Mechanisms|January 26, 2026
Enhanced lysosomal exocytosis and altered growth factor signaling are associated with cartilage pathology in a zebrafish model of MPSIVAJen-Jie Lee, Po-Nien Lu, Lynn Dukes-Rimsky, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
A non-canonical EZH2/TRIM28 epigenetic axis drives heparan sulfate remodeling and melanoma metastasisNeil G Patel, Alexandra Drakaki, Farhan Valummel, et al.
Cancer Research Communications|March 27, 2023
Identifying Good Candidates for Active Surveillance of Ductal Carcinoma <i>In Situ</i>: Insights from a Large Neoadjuvant Endocrine Therapy CohortAlexa C Glencer, Phoebe N Miller, Heather Greenwood, et al.
NPJ Breast Cancer|August 4, 2024
Magnetic resonance imaging insights from active surveillance of women with ductal carcinoma in situHeather I Greenwood, Cristian K Maldonado Rodas, Rita I Freimanis, et al.
Journal of the American Medical Informatics Association : JAMIA|August 19, 2024
Implementation and impact of an electronic patient reported outcomes system in a phase II multi-site adaptive platform clinical trial for early-stage breast cancerAnna Northrop, Anika Christofferson, Saumya Umashankar, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Glycan Profiling Identifies Chondroitin-4-sulfate as a Biomarker for Platinum Response and Therapeutic Target in Ovarian CancerErica J Peterson, James D Hampton, Ryan J Weiss, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2024
Glycosaminoglycan-mediated lipoprotein uptake protects cancer cells from ferroptosisDylan Calhoon, Lingjie Sang, Divya Bezwada, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 7, 2021
Th1 cytokine interferon gamma improves response in HER2 breast cancer by modulating the ubiquitin proteasomal pathwayYongsheng Jia, Krithika N Kodumudi, Ganesan Ramamoorthi, et al.
Pageof 8

Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
JAMIA Open|June 7, 2021
PRoBE the cloud toolkit: finding the best biomarkers of drug response within a breast cancer clinical trialNicholas O'Grady, David L Gibbs, Kawther Abdilleh, et al.
Frontiers in Oncology|June 29, 2023
Computational drug repositioning for the identification of new agents to sensitize drug-resistant breast tumors across treatments and receptor subtypesKatharine Yu, Amrita Basu, Christina Yau, et al.
Disease Models & Mechanisms|January 26, 2026
Enhanced lysosomal exocytosis and altered growth factor signaling are associated with cartilage pathology in a zebrafish model of MPSIVAJen-Jie Lee, Po-Nien Lu, Lynn Dukes-Rimsky, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
A non-canonical EZH2/TRIM28 epigenetic axis drives heparan sulfate remodeling and melanoma metastasisNeil G Patel, Alexandra Drakaki, Farhan Valummel, et al.
Cancer Research Communications|March 27, 2023
Identifying Good Candidates for Active Surveillance of Ductal Carcinoma <i>In Situ</i>: Insights from a Large Neoadjuvant Endocrine Therapy CohortAlexa C Glencer, Phoebe N Miller, Heather Greenwood, et al.
NPJ Breast Cancer|August 4, 2024
Magnetic resonance imaging insights from active surveillance of women with ductal carcinoma in situHeather I Greenwood, Cristian K Maldonado Rodas, Rita I Freimanis, et al.
Journal of the American Medical Informatics Association : JAMIA|August 19, 2024
Implementation and impact of an electronic patient reported outcomes system in a phase II multi-site adaptive platform clinical trial for early-stage breast cancerAnna Northrop, Anika Christofferson, Saumya Umashankar, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Glycan Profiling Identifies Chondroitin-4-sulfate as a Biomarker for Platinum Response and Therapeutic Target in Ovarian CancerErica J Peterson, James D Hampton, Ryan J Weiss, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2024
Glycosaminoglycan-mediated lipoprotein uptake protects cancer cells from ferroptosisDylan Calhoon, Lingjie Sang, Divya Bezwada, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 7, 2021
Th1 cytokine interferon gamma improves response in HER2 breast cancer by modulating the ubiquitin proteasomal pathwayYongsheng Jia, Krithika N Kodumudi, Ganesan Ramamoorthi, et al.
Pageof 8